Roche: prostate cancer study didn’t meet objective – MarketWatch
|
Roche: prostate cancer study didn't meet objective
MarketWatch … in men with late stage prostate cancer did not meet its primary objective of extending overall survival compared to chemotherapy and prednisone alone. … Roche's Avastin prostate cancer study misses goal Avastin Misses Prostrate-Cancer Goal Roche's Avastin Fails to Meet Goal of Prostate Study |
